Rapamycin-loaded nanocoating to specially modulate smooth muscle cells on ZE21B alloy for vascular stent application
Bibliographic record
Abstract
No abstract is available for this record. The assistant can identify its topic from the title, but cannot infer the study’s results.
Source: Not provided · Quality: missing
Research context
OpenAlex topics: Magnesium Alloys: Properties and Applications · Corrosion Behavior and Inhibition · Metal and Thin Film Mechanics
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (45)
Show source-provided references
1. Cardiovascular disease: Rise, fall, and future prospects10.1146/annurev-publhealth-112810-151726 ↗
2. Current treatment of in-stent restenosis10.1016/j.jacc.2014.02.545 ↗
3. Biodegradable metal stents: A focused review on materials and clinical studies10.1166/jbt.2014.1263 ↗
4. Processing and properties of magnesium alloy micro-tubes for biodegradable vascular stents10.1016/j.msec.2018.05.005 ↗
5. Bio-adaption between magnesium alloy stent and the blood vessel: A review10.1016/j.jmst.2015.12.018 ↗
6. Magnesium based degradable biomaterials: A review10.1007/s11706-014-0253-9 ↗
7. Mechanical properties of magnesium alloys for medical application: A review10.1016/j.jmbbm.2018.07.022 ↗
8. In vitro and in vivo cytocompatibility evaluation of biodegradable magnesium-based stents: A review10.1007/s40843-017-9194-y ↗
9. Layer-by-layer deposition of bioactive layers on magnesium alloy stent materials to improve corrosion resistance and biocompatibility
10. Design, preparation and performance of a novel drug-eluting stent with multiple layer coatings10.1039/C7BM00417F ↗
11. Polymer-bioceramic composite coatings on magnesium for biomaterial applications10.1016/j.surfcoat.2013.10.029 ↗
12. Mussel-inspired functionalization of PEO/PCL composite coating on a biodegradable AZ31 magnesium alloy10.1016/j.colsurfb.2016.02.004 ↗
13. In vitro and in vivo studies on two-step alkali-fluoride-treated Mg-Zn-Y-Nd alloy for vascular stent application: Enhancement in corrosion resistance and biocompatibility10.1021/acsbiomaterials.9b00140 ↗
14. A tannic acid-modified fluoride pre-treated Mg-Zn-Y-Nd alloy with antioxidant and platelet-repellent functionalities for vascular stent application10.1039/C9TB01587F ↗
15. Enhanced bioactivity of Mg-Nd-Zn-Zr alloy achieved with nanoscale MgF2 surface for vascular stent application10.1021/am5086885 ↗
16. Arginine-leucine based poly (ester urea urethane) coating for Mg-Zn-Y-Nd alloy in cardiovascular stent applications10.1016/j.colsurfb.2017.07.031 ↗
17. Functionalized polymeric membrane with enhanced mechanical and biological properties to control the degradation of magnesium alloy10.1002/adhm.201601269 ↗
18. Preparation of paclitaxel/chitosan co-assembled core-shell nanofibers for drug-eluting stent10.1016/j.apsusc.2016.10.015 ↗
19. In vitro and in vivo assessment of the biocompatibility of a paclitaxel-eluting poly-L-lactide-coated Mg-Zn-Y-Nd alloy stent in the intestine10.1016/j.msec.2019.110087 ↗
20. Dual drug-eluting stents coated with multilayers of hydrophobic heparin and sirolimus10.1021/am403615q ↗
21. Biodegradable sirolimus-loaded poly(lactide) nanoparticles as drug delivery system for the prevention of in-stent restenosis in coronary stent application10.1177/0885328209360696 ↗
22. Crystalline coating of rapamycin onto a stent: Process development and characterization10.1016/j.ijpharm.2013.01.053 ↗
23. Use of everolimus-eluting stent with a bioresorbable polymer coating for treatment of recurrent in-stent restenosis
24. Advances in coatings on magnesium alloys for cardiovascular stents-A review
25. Enhanced anti-corrosion ability and biocompatibility of PLGA coatings on MgZnYNd alloy by BTSE-APTES pre-treatment for cardiovascular stent10.1016/j.jmst.2016.06.021 ↗
26. Coronary stent materials and coatings: A technology and performance update10.1007/s10439-015-1380-x ↗
27. Enhanced in vitro and in vivo performance of Mg-Zn-Y-Nd alloy achieved with APTES pretreatment for drug-eluting vascular stent application10.1021/acsami.6b05038 ↗
28. Biodegradable depsipeptide-PDO-PEG-based block copolymer micelles as nanocarriers for controlled release of doxorubicin10.1016/j.reactfunctpolym.2014.06.005 ↗
29. Delivery of germacrone (GER) using macrophages-targeted polymeric nanoparticles and its application in rheumatoid arthritis10.1080/10717544.2022.2044936 ↗
30. Nanoparticles in drug delivery: Past, present and future10.1016/j.addr.2012.04.010 ↗
31. Drug loaded nanoparticle coating on totally bioresorbable PLLA stents to prevent in-stent restenosis10.1002/jbm.b.33794 ↗
32. Core-shell nanosystems for self-activated drug-gene combinations against triple-negative breast cancer10.1021/acsami.0c15089 ↗
33. Bone-targeting polymer vesicles for simultaneous imaging and effective malignant bone tumor treatment10.1016/j.biomaterials.2020.120345 ↗
34. Multifunctional peptide conjugated amphiphilic cationic copolymer for enhancing ECs targeting, penetrating and nuclear accumulation10.1007/s11705-020-1919-8 ↗
35. Val-Ala-Pro-Gly, an elastin-derived non-integrin ligand: Smooth muscle cell adhesion and specificity10.1002/jbm.a.10110 ↗
36. Functional electrospun fibrous scaffolds with dextran-g-poly(L-lysine)-VAPG/microRNA-145 to specially modulate vascular SMCs10.1039/C7TB01755C ↗
37. Microstructures and properties of biological Mg-Zn-Y-Nd alloy by friction stir processing10.4028/www.scientific.net/MSF.745-746.33 ↗
38. The microstructure and properties of cyclic extrusion compression treated Mg-Zn-Y-Nd alloy for vascular stent application10.1016/j.jmbbm.2011.12.011 ↗
39. Compared study of vascular cell response to Mg-Zn-Y-Nd and WE43 as biodegradable stents10.4028/www.scientific.net/AMR.915-916.962 ↗
40. Rapamycin-FKBP inhibits cell cycle regulators of proliferation in vascular smooth muscle cells10.1161/01.RES.76.3.412 ↗
41. Rapamune® (RAPA, rapamycin, sirolimus): Mechanism of action immunosuppressive effect results from blockade of signal transduction and inhibition of cell cycle progression10.1016/j.clinbiochem.2006.04.016 ↗
42. Biofunctionalized electrospun PCL-PIBMD/SF vascular grafts with PEG and cell-adhesive peptides for endothelialization10.1002/mabi.201800386 ↗
43. Fibrinogen binding and platelet retention: Relationship with the thrombogenicity of catheters10.1002/(SICI)1097-4636(199601)30:1<101::AID-JBM13>3.0.CO;2-R ↗
44. Surface modification and endothelialization of biomaterials as potential scaffolds for vascular tissue engineering applications10.1039/C4CS00483C ↗
45. TGF beta, smooth muscle cells and coronary artery disease: A review10.1016/j.cellsig.2018.09.004 ↗